サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1381031

粒子線治療市場：治療タイプ、コンポーネント、がんタイプ、エンドユーザー別-2023-2030年の世界予測

Particle Therapy Market by Therapy Type (Fast-Neutron Therapy, Heavy Ion Therapy, Proton Therapy), Component (Products, Systems), Cancer Type, End-User - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
粒子線治療市場：治療タイプ、コンポーネント、がんタイプ、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

粒子線治療市場は、2022年の6億7,852万米ドルから2030年には12億4,267万米ドルに達すると予測され、予測期間中のCAGRは7.85%です。

粒子線治療の世界市場

主な市場の統計
市場金額：基準年[2022] 6億7,852万米ドル
推定市場金額[2023] 7億2,344万米ドル
予測市場金額[2030]USD 1,242.67 million 12億4,267万米ドル
CAGR（%） 7.85%
粒子線治療 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは粒子線治療市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.粒子線治療市場の市場規模および予測は？

2.粒子線治療市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.粒子線治療市場における競争戦略の窓とは？

4.粒子線治療市場の最新技術動向と規制の枠組みは？

5.粒子線治療市場における主要ベンダーの市場シェアは？

6.粒子線治療市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • がん治療における高度な治療の必要性
      • 臨床試験における粒子線治療の採用の増加
      • 迅速、非侵襲的、痛みのない処置の導入が増加
    • 抑制要因
      • 粒子線治療に対する限定的な保険補償
    • 機会
      • 進行中の陽子線治療調査プログラム
      • 荷電粒子治療における技術の進歩
    • 課題
      • 新興国における患者の粒子線治療に関する認識の欠如
      • 粒子線治療放射線被曝に伴うリスク
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 粒子線治療市場治療タイプ別

  • 速中性子療法
  • 重粒子線治療
  • 陽子線治療

第7章 粒子線治療市場：コンポーネント別

  • 製品
    • サイクロトロン
    • シンクロサイクロトロン
    • シンクロトロン
  • システム
    • マルチルームシステム
    • 個室システム

第8章 粒子線治療市場がんの種類別

  • 乳がん
  • 頭頸部がん
  • 肺がん
  • 小児がん
  • 前立腺がん

第9章 粒子線治療市場：エンドユーザー別

  • 外来手術センター
  • 病院とクリニック

第10章 南北アメリカの粒子線治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の粒子線治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの粒子線治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Advanced Oncotherapy plc
    • Danfysik A/S
    • Elekta AB
    • Hitachi, Ltd.
    • IBA International
    • Koninklijke Philips N.V.
    • Mevion Medical Systems
    • Mitsubishi Electric Corporation
    • Optivus Proton Therapy, Inc.
    • ProTom International
    • Provision Healthcare, LLC
    • PTW Freiburg GmbH
    • SAH Global LLC
    • Sumitomo Heavy Industries, Ltd.
    • Toshiba Medical Systems Corporation
    • Varian Medical Systems, Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PARTICLE THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. PARTICLE THERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
  • FIGURE 7. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 10. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
  • FIGURE 12. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PARTICLE THERAPY MARKET SIZE, BY FAST-NEUTRON THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 10. PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 12. PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 17. PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 279. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 280. PARTICLE THERAPY MARKET LICENSE & PRICING
目次
Product Code: MRR-335201F2E2D7

The Particle Therapy Market is projected to reach USD 1,242.67 million by 2030 from USD 678.52 million in 2022, at a CAGR of 7.85% during the forecast period.

Global Particle Therapy Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 678.52 million
Estimated Year Value [2023] USD 723.44 million
Forecast Year Value [2030] USD 1,242.67 million
CAGR (%) 7.85%
Particle Therapy Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Particle Therapy Market.

Based on Therapy Type, market is studied across Fast-Neutron Therapy, Heavy Ion Therapy, and Proton Therapy. The Proton Therapy is projected to witness significant market share during forecast period.

Based on Component, market is studied across Products and Systems. The Products is further studied across Cyclotrons, Synchrocyclotrons, and Synchrotrons. The Systems is further studied across Multi-Room Systems and Single-Room Systems. The Systems is projected to witness significant market share during forecast period.

Based on Cancer Type, market is studied across Breast Cancer, Head & Neck Cancer, Lung Cancer, Pediatric Cancer, and Prostate Cancer. The Prostate Cancer is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Particle Therapy Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Particle Therapy Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, Optivus Proton Therapy, Inc., ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Varian Medical Systems, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Particle Therapy Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Particle Therapy Market?

3. What is the competitive strategic window for identifying opportunities in the Particle Therapy Market?

4. What are the latest technology trends and regulatory frameworks in the Particle Therapy Market?

5. What is the market share of the leading vendors in the Particle Therapy Market?

6. Which modes and strategic moves are suitable for entering the Particle Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Particle Therapy Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for advanced therapies in cancer treatment
      • 5.1.1.2. Rise in adoption of particle therapy in clinical trials
      • 5.1.1.3. Increasing adoption of fast, non-invasive, and painless procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Limited insurance coverage for particle therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing proton therapy research programs
      • 5.1.3.2. Technological advances in charged-particle therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness in patients about particle therapy in the emerging economies
      • 5.1.4.2. Risk associated with the particle therapy radiation exposure
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Particle Therapy Market, by Therapy Type

  • 6.1. Introduction
  • 6.2. Fast-Neutron Therapy
  • 6.3. Heavy Ion Therapy
  • 6.4. Proton Therapy

7. Particle Therapy Market, by Component

  • 7.1. Introduction
  • 7.2. Products
    • 7.3.1. Cyclotrons
    • 7.3.2. Synchrocyclotrons
    • 7.3.3. Synchrotrons
  • 7.3. Systems
    • 7.4.1. Multi-Room Systems
    • 7.4.2. Single-Room Systems

8. Particle Therapy Market, by Cancer Type

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Head & Neck Cancer
  • 8.4. Lung Cancer
  • 8.5. Pediatric Cancer
  • 8.6. Prostate Cancer

9. Particle Therapy Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Hospitals & Clinics

10. Americas Particle Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Particle Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Particle Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Advanced Oncotherapy plc
    • 14.1.2. Danfysik A/S
    • 14.1.3. Elekta AB
    • 14.1.4. Hitachi, Ltd.
    • 14.1.5. IBA International
    • 14.1.6. Koninklijke Philips N.V.
    • 14.1.7. Mevion Medical Systems
    • 14.1.8. Mitsubishi Electric Corporation
    • 14.1.9. Optivus Proton Therapy, Inc.
    • 14.1.10. ProTom International
    • 14.1.11. Provision Healthcare, LLC
    • 14.1.12. PTW Freiburg GmbH
    • 14.1.13. SAH Global LLC
    • 14.1.14. Sumitomo Heavy Industries, Ltd.
    • 14.1.15. Toshiba Medical Systems Corporation
    • 14.1.16. Varian Medical Systems, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing